TY  - JOUR
AU  - Gomez-Garcia, Francisco
AU  - Sanz-Cabanillas, Juan L.
AU  - Viguera-Guerra, Isabel
AU  - Isla-Tejera, Beatriz
AU  - Velez-Garcia Nieto, Antonio 
AU  - Ruano, Juan
PY  - 2018
DO  - 10.1007/s13555-018-0269-7
SN  - 2193-8210
UR  - http://hdl.handle.net/10668/13152
T2  - Dermatology and Therapy
AB  - Deficiencies in interleukin (IL)-1 receptor (IL-R) antagonist (DIRA) and IL-36R antagonist (DITRA) are rare genetic autoinflammatory diseases related to alterations in antagonists of the IL-1 pathway. IL-1 antagonists may represent therapeutic...
LA  - en
PB  - Springer Link
KW  - Anakinra
KW  - Anti-IL-1 drugs
KW  - Canakinumab
KW  - Deficiency of IL-36R antagonist (DITRA)
KW  - Deficiency of interleukin(IL)-1 receptor(R) antagonist (DIRA)
KW  - Genetic autoinflammatory diseases
KW  - Rilonacept
KW  - Scoping review
KW  - Humans
KW  - canakinumab
KW  - Interleukin 1 Receptor Antagonist Protein
KW  - Hereditary Autoinflammatory Diseases
KW  - Mutation
KW  - Interleukin-1
KW  - Necrosis
TI  - Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA.
TY  - research article
VL  - 8
ER  -